Table 6 Success in achieving target values in our own and in EUROASPIRE V
Very high-risk patients | Three Generations for Health Study | EUROASPIRE V | ||
|---|---|---|---|---|
On target | ||||
Risk factor and target value | Total | Male | Female | Total (n = 8261) |
Total cholesterol: < 3.5 mmol/l | 4.7% (n = 550/11728) | 6.1% (n = 355/5843) | 3.3% (n = 195/5885) | |
LDL-cholesterol: < 1.8 mmol/l | 8.0% (n = 916/11463) | 9.5% (n = 539/5687) | 6.5% (n = 377/5776) | 29% |
HDL-cholesterol: male: > 1.0 mmol/l, female: > 1.3 mmol/l | 75.4% (n = 8842/11728) | 85.0% (n = 4964/5843) | 65.9% (n = 3878/5885) | |
Triglyceride: < 1.7 mmol/l | 55.0% (n = 6450/11728) | 51.8% (n = 3025/5843) | 58.2% (n = 3425/5885) | |
Blood pressure: < 140/90 mmHg (diabetes: < 140/85 mmHg, nephropathy + proteinuria: < 130/80 mmHg) | 49.9% (n = 5842/11709) | 42.8% (n = 2495/5834) | 57.0% (n = 3347/5875) | 58% |
HbA1c < 7% (patients with type 2 diabetes) | 53.0% (n = 2217/4183) | 50.3% (n = 1066/2121) | 55.8% (n = 1151/2062) | 54% (n = 29% of all patients) |
BMI < 25 kg/m2 | 17.4% (n = 2038/11698) | 15.0% (n = 876/5829) | 19.8% (n = 1162/5869) | 18% |
Waist circumference (male: < 102 cm, female: < 88 cm) | 29.4% (n = 3166/10784) | 39.3% (n = 2104/5348) | 19.6% (n = 1062/5436) | 41% |
Waist circumference (male: < 94 cm, female: < 80 cm) | 14.3% (n = 1543/10784) | 21.4% (n = 1143/5348) | 7.4% (n = 400/5436) | |